stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / BIIB / Gross Profit

Biogen Inc. Gross Profit 2007–2025

Biogen Inc. (BIIB) annual gross profit by fiscal year, computed from SEC filings. Compound growth +5.5%/yr over 18 years.

Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$7.49B75.7%+1.6%
FY 2024$7.37B76.1%+0.9%
FY 2023$7.30B74.2%-7.5%
FY 2022$7.90B77.6%-11.0%
FY 2021$8.87B80.8%-23.8%
FY 2020$11.64B86.6%-6.3%
FY 2019$12.42B86.4%+6.8%
FY 2018$11.64B86.5%+9.3%
FY 2017$10.64B86.7%+6.8%
FY 2016$9.97B87.1%+4.7%
FY 2015$9.52B88.5%+11.6%
FY 2014$8.53B87.9%+40.5%
FY 2013$6.07B87.6%+22.2%
FY 2012$4.97B90.1%+8.5%
FY 2011$4.58B90.8%+6.2%
FY 2010$4.32B91.5%+8.0%
FY 2009$4.00B91.3%+8.1%
FY 2008$3.70B90.2%+30.3%
FY 2007$2.84B89.4%

Source: Biogen Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Biogen Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Biogen Inc. — frequently asked questions

What is Biogen Inc.'s gross profit?

Biogen Inc. (BIIB) reported gross profit of $7.49B for fiscal year 2025, per its SEC filings.

How has Biogen Inc.'s gross profit changed over time?

Between fiscal 2007 and 2025, BIIB's gross profit grew at roughly 5.5% per year (compound annual rate), from $2.84B to $7.49B.

Where does this data come from?

Figures are computed from Biogen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More BIIB financial history

Full BIIB fundamentals page → · All 1,500+ companies →